Search

Your search keyword '"Chantrill, Lorraine"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Chantrill, Lorraine" Remove constraint Author: "Chantrill, Lorraine"
242 results on '"Chantrill, Lorraine"'

Search Results

1. DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol

2. SCANPatient: study protocol for a multi-centre, batched, stepped wedge, comparative effectiveness, randomised clinical trial of synoptic reporting of computerised tomography (CT) scans assessing cancers of the pancreas

3. Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Expert consensus on the optimal management of BRAFV600E‐mutant metastatic colorectal cancer in the Asia‐Pacific region.

6. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

7. MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

8. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer

9. Whole genomes redefine the mutational landscape of pancreatic cancer

11. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus

12. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.

13. NABNEC: A randomised phase II study of nab -paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas (GI-NECs).

14. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer

15. Does Geography Play a Role in the Receipt of End-of-Life Care for Advanced Cancer Patients? Evidence from an Australian Local Health District Population-Based Study.

17. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

18. Combined burden and functional impact tests for cancer driver discovery using DriverPower

19. Integrative pathway enrichment analysis of multivariate omics data

20. Pathway and network analysis of more than 2500 whole cancer genomes

21. Divergent mutational processes distinguish hypoxic and normoxic tumours

22. Genomic footprints of activated telomere maintenance mechanisms in cancer

23. Pancreatic cancer

26. Genomic analyses identify molecular subtypes of pancreatic cancer

27. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

28. Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours

29. Whole-genome landscape of pancreatic neuroendocrine tumours

31. Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers

32. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence

33. European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions

34. Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

35. Cancer of the pancreas.

37. Whole genomes redefine the mutational landscape of pancreatic cancer

38. Precision Oncology in Surgery

39. Combination chemotherapy with NAB®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study).

40. Clinical and pathologic features of familial pancreatic cancer

42. Combination chemotherapy with NAB ® ‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study)

43. DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

44. Additional file 1 of MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG)

45. Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.

47. Pan-cancer analysis of whole genomes

48. Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

49. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma

50. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer

Catalog

Books, media, physical & digital resources